Antibiotic Therapy of 3 Days May Be Sufficient After Biliary Drainage for Acute Cholangitis: A Systematic Review

Sylke Haal, Mattheus C B Wielenga, Paul Fockens, Charlotte A Leseman, Cyriel Y Ponsioen, Ellert J van Soest, Roy L J van Wanrooij, Elske Sieswerda, Rogier P Voermans, Sylke Haal, Mattheus C B Wielenga, Paul Fockens, Charlotte A Leseman, Cyriel Y Ponsioen, Ellert J van Soest, Roy L J van Wanrooij, Elske Sieswerda, Rogier P Voermans

Abstract

Background: The optimal antibiotic therapy duration for cholangitis is unclear. Guideline recommendations vary between 4 and 14 days after biliary drainage. Clinical observations and some evidence however suggest that shorter antibiotic therapy may be sufficient.

Objective: To compare the effectiveness and safety of short-course therapy of ≤ 3 days with long-course therapy of ≥ 4 days after biliary drainage in cholangitis patients.

Methods: We searched the databases PubMed, EMBASE, Cochrane Library, and trial registers for literature up to August 5, 2020. RCTs and observational studies including case series reporting on antibiotic therapy duration for acute cholangitis were eligible for inclusion. Two reviewers independently evaluated study eligibility, extracted data, assessed risk of bias and quality of evidence. A meta-analysis was planned if the included studies were comparable with regard to important study characteristics. Primary outcomes included recurrent cholangitis, subsequent other infection, and mortality.

Results: We included eight studies with 938 cholangitis patients. Four observational studies enrolled patients treated for ≤ 3 days. Recurrent cholangitis occurred in 0-26.8% of patients treated with short-course therapy, which did not differ from long-course therapy (range 0-21.1%). Subsequent other infection and mortality rates were also comparable. Quality of available evidence was very low.

Conclusion: There is no high-quality evidence available to draw a strong conclusion, but heterogeneous observational studies suggest that antibiotic therapy of ≤ 3 days is sufficient in cholangitis patients with common bile duct stones.

Keywords: Acute cholangitis; Antibiotic therapy duration; Antimicrobial stewardship; Biliary drainage; Systematic review.

Conflict of interest statement

The authors declare that they have no conflict of interest.

© 2021. The Author(s).

Figures

Fig. 1
Fig. 1
PRISMA flowchart showing study selection

References

    1. Miura F, Okamoto K, Takada T, et al. Tokyo Guidelines 2018: initial management of acute biliary infection and flowchart for acute cholangitis. J Hepatobiliary Pancreat Sci. 2018;25:31–40. doi: 10.1002/jhbp.509.
    1. van den Hazel SJ, Speelman P, Tytgat GN, Dankert J, van Leeuwen DJ. Role of antibiotics in the treatment and prevention of acute and recurrent cholangitis. Clin Infect Dis. 1994;19:279–286. doi: 10.1093/clinids/19.2.279.
    1. Gomi H, Solomkin JS, Schlossberg D, et al. Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci. 2018;25:3–16. doi: 10.1002/jhbp.518.
    1. Sieswerda E, Bax HI, Hoogerwerf JJ, et al. The Dutch Working Party on Antibiotic Policy (SWAB) guidelines for emperical antibacterial therapy of sepsis in adults. 2020. . Accessed December 2020.
    1. Sawyer RG, Claridge JA, Nathens AB, et al. Trial of short-course antimicrobial therapy for intraabdominal infection. N Engl J Med. 2015;372:1996–2005. doi: 10.1056/NEJMoa1411162.
    1. Hassinger TE, Guidry CA, Rotstein OD, et al. Longer-duration antimicrobial therapy does not prevent treatment failure in high-risk patients with complicated intra-abdominal infections. Surg Infect (Larchmt) 2017;18:659–663. doi: 10.1089/sur.2017.084.
    1. Rattan R, Allen CJ, Sawyer RG, et al. Patients with complicated intra-abdominal infection presenting with sepsis do not require longer duration of antimicrobial therapy. J Am Coll Surg. 2016;222:440–446. doi: 10.1016/j.jamcollsurg.2015.12.050.
    1. Mazuski JE, Tessier JM, May AK, et al. The surgical infection society revised guidelines on the management of intra-abdominal infection. Surg Infect (Larchmt) 2017;18:1–76. doi: 10.1089/sur.2016.261.
    1. Sartelli M, Chichom-Mefire A, Labricciosa FM, et al. The management of intra-abdominal infections from a global perspective: 2017 WSES guidelines for management of intra-abdominal infections. World J Emerg Surg. 2017;12:29. doi: 10.1186/s13017-017-0141-6.
    1. Rhodes A, Evans LE, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017;43:304–377. doi: 10.1007/s00134-017-4683-6.
    1. Haal S, Ten Böhmer B, Balkema S, et al. Antimicrobial therapy of 3 days or less is sufficient after successful ERCP for acute cholangitis. United Eur Gastroenterol J. 2020;8:481–488. doi: 10.1177/2050640620915016.
    1. Bell BG, Schellevis F, Stobberingh E, Goossens H, Pringle M. A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance. BMC Infect Dis. 2014;14:13. doi: 10.1186/1471-2334-14-13.
    1. Marston HD, Dixon DM, Knisely JM, Palmore TN, Fauci AS. Antimicrobial resistance. JAMA. 2016;316:1193–1204. doi: 10.1001/jama.2016.11764.
    1. Riccio LM, Popovsky KA, Hranjec T, et al. Association of excessive duration of antibiotic therapy for intra-abdominal infection with subsequent extra-abdominal infection and death: a study of 2,552 consecutive infections. Surg Infect (Larchmt) 2014;15:417–424. doi: 10.1089/sur.2012.077.
    1. Sartelli M, Weber DG, Ruppe E, et al. Antimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA) World J Emerg Surg. 2016;11:33. doi: 10.1186/s13017-016-0089-y.
    1. Tamma PD, Avdic E, Li DX, Dzintars K, Cosgrove SE. Association of adverse events with antibiotic use in hospitalized patients. JAMA Intern Med. 2017;177:1308–1315. doi: 10.1001/jamainternmed.2017.1938.
    1. Tinusz B, Szapáry L, Paládi B, et al. Short-course antibiotic treatment is not inferior to a long-course one in acute cholangitis: a systematic review. Dig Dis Sci. 2019;64:307–315. doi: 10.1007/s10620-018-5327-6.
    1. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535. doi: 10.1136/bmj.b2535.
    1. Sterne JA, Hernán MA, Reeves BC, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919. doi: 10.1136/bmj.i4919.
    1. Sterne JAC, Savović J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898. doi: 10.1136/bmj.l4898.
    1. Wells GA, Shea B, O'Connell D et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. . Accessed January 2020.
    1. Ruynosuke H, Yousuke N. Fever-based versus guideline-based antiobiotic therapy for acute cholangitis following successful endoscopic biliary drainage: a multicenter randomized trial (FANTASTIC trial). UMIN000019814. . Accessed August 2020.
    1. Garret C. Is short antibiotherapy duration after drainage suitable for patients admitted in the intensive care medicine with a sever acute cholangitis? (CASCAD) NCT04173286. . Accessed August 2020
    1. Iwata K, Doi A, Oba Y, et al. Shortening antibiotic duration in the treatment of acute cholangitis: rationale and study protocol for an open-label randomized controlled trial. Trials. 2020;21:97. doi: 10.1186/s13063-020-4046-4.
    1. Doi A, Morimoto T, Iwata K. Shorter duration of antibiotic treatment for acute bacteraemic cholangitis with successful biliary drainage: a retrospective cohort study. Clin Microbiol Infect. 2018;24:1184–1189. doi: 10.1016/j.cmi.2018.01.021.
    1. Kogure H, Tsujino T, Yamamoto K, et al. Fever-based antibiotic therapy for acute cholangitis following successful endoscopic biliary drainage. J Gastroenterol. 2011;46:1411–1417. doi: 10.1007/s00535-011-0451-5.
    1. Netinatsunton N, Limmathurotsakul D, Attasaranya S, et al. Short duration versus 14-day antibiotic treatment in acute cholangitis due to bile duct stone: a randomized study. J Gastroenterol Hepatol Res. 2019;8:3020–3024.
    1. Park TY, Choi JS, Song TJ, et al. Early oral antibiotic switch compared with conventional intravenous antibiotic therapy for acute cholangitis with bacteremia. Dig Dis Sci. 2014;59:2790–2796. doi: 10.1007/s10620-014-3233-0.
    1. Uno S, Hase R, Kobayashi M, et al. Short-course antimicrobial treatment for acute cholangitis with Gram-negative bacillary bacteremia. Int J Infect Dis. 2017;55:81–85. doi: 10.1016/j.ijid.2016.12.018.
    1. van Lent AU, Bartelsman JF, Tytgat GN, Speelman P, Prins JM. Duration of antibiotic therapy for cholangitis after successful endoscopic drainage of the biliary tract. Gastrointest Endosc. 2002;55:518–522. doi: 10.1067/mge.2002.122334.
    1. Satake M, Yamaguchi Y. Three-day antibiotic treatment for acute cholangitis due to choledocholithiasis with successful biliary duct drainage: a single-center retrospective cohort study. Int J Infect Dis. 2020;96:343–347. doi: 10.1016/j.ijid.2020.04.074.
    1. Du L, Cen M, Zheng X, et al. Timing of performing endoscopic retrograde cholangiopancreatography and inpatient mortality in acute cholangitis: a systematic review and meta-analysis. Clin Transl Gastroenterol. 2020;11:e00158. doi: 10.14309/ctg.0000000000000158.
    1. Manes G, Paspatis G, Aabakken L, et al. Endoscopic management of common bile duct stones: European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy. 2019;51:472–491. doi: 10.1055/a-0862-0346.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe